secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2026-07-16T20:12:27+00:00
Accession:  0001193125-26-306117
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla stockholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- Jay M. Short and Edward Williams elected as Class III directors with ~70% of votes cast (excluding broker non-votes).
- Ernst & Young ratified as independent auditor for FY2026: 869,667 for, 18,545 against, 18,771 abstentions.
- Non-binding advisory vote on executive compensation approved: 281,294 for, 96,492 against, 69,033 abstentions.
- Approximately 55% of outstanding shares (906,983 shares) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526306117/0001193125-26-306117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000119312526306117/bcab-20260716.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-306117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer